Eğitim Bilgileri
2005 - 2008
2005 - 2008Tıpta Yandal Uzmanlık
İstanbul Üniversitesi, Cerrahpaşa Tıp Fakültesi, İç Hastalıkları Gastroenteroloji, Türkiye
1999 - 2004
1999 - 2004Tıpta Uzmanlık
İstanbul Üniversitesi, Cerrahpaşa Tıp Fakültesi, İç Hastalıkları, Türkiye
Yaptığı Tezler
2004
2004Tıpta Uzmanlık
Karaciğer enzim yüksekliğinin toplumdaki sıklığı ve olası etiolojik ilişkiler
İstanbul Üniversitesi, İç Hastalıkları, Gastroenteroloji
Yabancı Diller
C1 İleri
C1 İleriİngilizce
Araştırma Alanları
Tıp
Sağlık Bilimleri
Dahili Tıp Bilimleri
İç Hastalıkları
Gastroenteroloji-(Hepatoloji)
Akademik Faaliyetlere Dayalı Araştırma Alanları
Avesis Araştırma Alanları
WoS Araştırma Alanları
Scopus Araştırma Alanları
Akademik Ünvanlar / Görevler
2012 - Devam Ediyor
2012 - Devam EdiyorProf. Dr.
İstanbul Üniversitesi, Dahili Tıp Bilimleri
Makaleler
Tümü (97)
SCI-E, SSCI, AHCI (86)
SCI-E, SSCI, AHCI, ESCI (91)
ESCI (3)
Scopus (94)
TRDizin (14)
Diğer Yayınlar (1)
2026
20261. Ustekinumab may have therapeutic effects on autoimmune thyroid disease
Guzel S. S., DEMİR A., EŞKAZAN T., HATEMİ A. İ., GÖNEN M. S.
Scientific Reports
, cilt.16, sa.1, 2026 (SCI-Expanded, Scopus)
2026
20262. Isolated vs Crohn's Disease-Related Complex Perianal Fistulas: Similar Profiles but Challenging Fistula Phenotype with Delayed Radiological Healing in Isolated Disease
Bickes E., BAKKALOĞLU O. K., Bayar M., Akpinar A., Eskazan T., Sirolu S., et al.
JOURNAL OF CROHNS & COLITIS
, cilt.20, 2026 (SCI-Expanded, Scopus)
2026
20263. Upadacitinib Rescue in Steroid- and Infliximab-Refractory Acute Severe Ulcerative Colitis: Remission in Half of Patients at 1 Year
BAKKALOĞLU O. K., ÜNAL KOCABAŞ G., Akpinar A., Eskazan T., Akincioglu P., Kilic G., et al.
JOURNAL OF CROHNS & COLITIS
, cilt.20, 2026 (SCI-Expanded, Scopus)
2026
20264. Prevalence of Persistent Ultrasound Activity in Ulcerative Colitis Patients Despite Endoscopic Remission
Eskazan T., Ceylan G., Alasgarli S., Kati O., Akpinar A., BAKKALOĞLU O. K., et al.
JOURNAL OF CROHNS & COLITIS
, cilt.20, 2026 (SCI-Expanded, Scopus)
2026
20265. Intravenous versus Subcutaneous Infliximab in Perianal Fistulizing Crohn's Disease: A Two-Centre Real-World Comparison of Clinical, Endoscopic and Radiologic Outcomes
Akpinar A., BAKKALOĞLU O. K., ÜNAL KOCABAŞ G., Baytar S., Kati O., Eskazan T., et al.
JOURNAL OF CROHNS & COLITIS
, cilt.20, 2026 (SCI-Expanded, Scopus)
2025
20256. Efficacy and Safety of JAK Inhibitors in Behcet's Syndrome: A Systematic Literature Review
Sulu B., ESATOĞLU S. N., HATEMİ A. İ., ÇELİK A. F., HATEMİ G.
ARTHRITIS & RHEUMATOLOGY
, cilt.77, ss.421-422, 2025 (SCI-Expanded, Scopus)
2025
20257. Long-Term Oral Budesonide Use in Inflammatory Bowel Disease: Effects on Bone Mineral Density and Late-Onset Adverse Events
Eskazan T., BAKKALOĞLU O. K., DURCAN E., Akpinar A., Kurt E. A., Onal U., et al.
DIAGNOSTICS
, cilt.15, sa.17, 2025 (SCI-Expanded, Scopus)
2025
20258. Kronik karaciğer hastalıklarında FIB-4 ve APRI skorlarının klinik tanı ile uyumu
PEKER P., HATEMI A. I.
Ege Tıp Dergisi
, cilt.64, sa.2, ss.274-282, 2025 (TRDizin)
2025
20259. Efficacy and Safety of Infliximab in Patients with Autoimmune Hepatitis
Efe C., Lytvyak E., Eşkazan T., Liberal R., Androutsakos T., Gökçe D. T., et al.
Hepatology
, cilt.81, sa.6, ss.1660-1670, 2025 (SCI-Expanded, Scopus)
2025
202510. Long-Term Impact of COVID-19 on Disorders of Gut–Brain Interaction: Incidence, Symptom Burden, and Psychological Comorbidities
Marasco G., Hod K., Colecchia L., Cremon C., Barbaro M. R., Cacciari G., et al.
United European Gastroenterology Journal
, cilt.13, sa.5, ss.798-818, 2025 (SCI-Expanded, Scopus)
2025
202511. De novo manifestations during adalimumab treatment in Behçet's syndrome
ESATOĞLU S. N., SÖNMEZ Ö., UÇAR D., Kaymaz E., ÖZGÜLER Y., UĞURLU S., et al.
RHEUMATOLOGY
, cilt.64, sa.4, ss.2034-2040, 2025 (SCI-Expanded, Scopus)
2025
202512. Psychological and Clinical Factors Mediate Post-COVID-19 Irritable Bowel Syndrome
Hod K., Marasco G., Colecchia L., Cremon C., Barbaro M. R., Cacciari G., et al.
Neurogastroenterology and Motility
, 2025 (SCI-Expanded, Scopus)
2025
202513. P1117 A 24-year, single-centre perianal fistulizing Crohn’s disease cohort: documentation of demographics and factors influencing clinical and radiological remission
Bayar M., Bakkaloğlu O. K., Şirolu S., Sarı E., Hamid R., Tutar O., et al.
JOURNAL OF CROHN'S AND COLITIS , cilt.1, sa.19, ss.1117, 2025 (SCI-Expanded, Scopus)
2025
202514. Exploring congenital sucrase-isomaltase deficiency in autism spectrum disorder patients with irritable bowel syndrome symptoms: A prospective SI gene sequencing study.
Zubarioglu T., Ulgen D., Akca-Yesil S., Akbulut S., Onay H., Uzunyayla-Inci G., et al.
Autism research : official journal of the International Society for Autism Research
, cilt.18, sa.1, ss.44-55, 2025 (SCI-Expanded, SSCI, Scopus)
2024
202415. COVID-19 Seroprevalence in Cirrhotic Patients and Effect of COVID-19 Infection on Liver Cirrhosis by Clinical Form in the Postinfectious Period
Oenal U., Oezbey D., Bakkaloglu O. K., EŞKAZAN T., Kurt E. A., HATEMİ A. İ., et al.
ISTANBUL MEDICAL JOURNAL
, sa.4, ss.304-310, 2024 (ESCI, TRDizin)
2024
202416. Comparative Value of CRP and FCP for Endoscopic and Histologic Remissions in Ulcerative Colitis
Bakkaloglu O. K., Sen G., KEPİL N., EŞKAZAN T., Kurt E. A., Onal U., et al.
DIAGNOSTICS
, cilt.14, sa.20, 2024 (SCI-Expanded, Scopus)
2024
202417. Ascites does not accompany pleural effusion developing under dasatinib therapy in patients with CML-CP.
Küçükyurt S., EŞKAZAN T., Ayer M., Klllçklran Avcl B., Hatemi I., EŞKAZAN A. E.
Pleura and peritoneum
, cilt.9, sa.1, ss.39-43, 2024 (ESCI)
2024
202418. P856 Influential factors on the clinical and radiological closure of resistant perianal fistula treated with stoma
Candan S., Bakkaloglu O. K., Bayar M., Eskazan T., Hatemi I., Erzin Y., et al.
JOURNAL OF CROHN'S AND COLITIS , cilt.1, sa.18, ss.856, 2024 (SCI-Expanded, Scopus)
2024
202419. Prevalance and risk factors of thromboembolism in Inflammatory Bowel Disease
Kati O., Bakkaloglu O. K., Hatemi I., Celik A. F., SEYAHİ E., Erzin Y.
JOURNAL OF CROHNS & COLITIS
, 2024 (SCI-Expanded, Scopus)
2023
202320. Diagnosis and Treatment of Autoimmune Hepatitis: Questions, Answers, and Illustrative Cases: Endorsed by Autoimmune Liver Diseases Special Interest Group, Turkish Association for the Study of Liver
Ozaslan E., GÜNŞAR F., Ormeci A. C., HATEMİ A. İ., Efe C., AKYOL G., et al.
TURKISH JOURNAL OF GASTROENTEROLOGY
, cilt.34, 2023 (SCI-Expanded, Scopus, TRDizin)
2023
202321. Axial Spondyloarthritis in Patients with Gastrointestinal Involvement of Behcet Syndrome
ÖZTÜRK M., ESATOĞLU S. N., HATEMİ A. İ., ÇELİK A. F., KARGIN O. A., ÖZ A., et al.
ARTHRITIS & RHEUMATOLOGY
, ss.3067-3068, 2023 (SCI-Expanded, Scopus)
2023
202322. Abdominal Surgical Interventions Among Patients with Gastrointestinal Involvement of Behcet Syndrome
ESATOĞLU S. N., GÜNER S., Guler S., HATEMİ G., KEPİL N., ERZİN Y. Z., et al.
ARTHRITIS & RHEUMATOLOGY
, ss.3068-3070, 2023 (SCI-Expanded, Scopus)
2023
202323. Increase in transaminase levels during COVID-19 infection and its association with poor prognosis
Bakkaloglu O. K., Onal U., Eskazan T., Kurt E. A., Candan S., Karaali R., et al.
SINGAPORE MEDICAL JOURNAL
, cilt.64, sa.10, ss.640-644, 2023 (SCI-Expanded, Scopus)
2023
202324. Is There A Connection Between Primary Hypophysitis and Celiac Disease?
Kara Z., EŞKAZAN T., ŞAHİN S., Durcan E., Sulu C., Demir A. N., et al.
EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES
, cilt.132, sa.1, ss.33-38, 2023 (SCI-Expanded, Scopus)
2023
202325. RE: Is There a More Practical Way for Screening Minimal Hepatic Encephalopathy?
Eyice D., Ok A. M., Sonsuz A., Şenocak M. Ş., Durak M. N., Özdemir S., et al.
The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology
, cilt.34, sa.6, ss.673, 2023 (SCI-Expanded, Scopus, TRDizin)
2022
202226. Recurrent colorectal carcinoma presenting with ileus dueto small bowel metastases: A case report
Ak T., Copur M., Candan S., Hatemi A. İ.
Medicina Clinica Practica , cilt.6, sa.1, ss.0-11, 2022 (Scopus)
2018
201827. Immunogenicity of infliximab among patients with Behcet's syndrome: a controlled study
Esatoglu S. N., Akkoc F. N., Ozguler Y., Ozbakir F., Nohut O. K., Cevirgen D., et al.
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY
, cilt.36, sa.6, 2018 (SCI-Expanded, Scopus)
2017
201728. Prevalence of fecal incontinence and associated risk factors in elderly outpatients: a cross-sectional study
Demir N., Yuruyen M., Atay K., Yavuzer H., Hatemi I., Doventas A., et al.
Aging Clinical and Experimental Research
, cilt.29, sa.6, ss.1165-1171, 2017 (SCI-Expanded, Scopus)
2017
201729. What is the long term acid inhibitor treatment in gastroesophageal reflux disease? What are the potential problems related to long term acid inhibitor treatment in gastroesophageal reflux disease? How should these cases be followed?
HATEMI I., Esatoğlu S. N.
TURKISH JOURNAL OF GASTROENTEROLOGY
, cilt.28, 2017 (SCI-Expanded, Scopus, TRDizin)
2017
201730. Immunogenicity of Infliximab Among Patients with Behcet's Syndrome: A Controlled Study
Esatoglu S. N., Akkoc F. N., Ozguler Y., Ozbakir F., Nohut O. K., Cevirgen D., et al.
ARTHRITIS & RHEUMATOLOGY
, cilt.69, 2017 (SCI-Expanded, Scopus)
2017
201731. Behçet's syndrome: providing integrated care.
Esatoglu S. N., Kutlubay Z., Ucar D., Hatemi I., Uygunoglu U., Siva A., et al.
Journal of multidisciplinary healthcare
, cilt.10, ss.309-319, 2017 (Scopus)
2017
201732. Apoptosis and Disease Severity is Associated with Insulin Resistance in Nonalcoholic Fatty Liver Disease
Atay K., Canbakan B., Koroglu E., Hatemi I., Canbakan M., Kepil N., et al.
ACTA GASTRO-ENTEROLOGICA BELGICA
, cilt.80, sa.2, ss.271-277, 2017 (SCI-Expanded, Scopus)
2017
201733. Did toxicity profile of azathioprine changed within the last 10 years: comparative 17 years data from a single tertiary IBD center
Bozcan S., Hatemi I., Yildirim S., Demir N., Erzin Y., Celik A. F.
JOURNAL OF CROHNS & COLITIS
, cilt.11, 2017 (SCI-Expanded, Scopus)
2017
201734. What is the diagnostic accuracy of faecal calprotectin regarding endoscopic relapse in Crohn's disease patients following ileocecal resection? A tertiary single center experience
Yildirim S., Demir N., Bozcan S., Erzin Y., Hatemi I., Celik A. F.
JOURNAL OF CROHNS & COLITIS
, cilt.11, 2017 (SCI-Expanded, Scopus)
2017
201735. Mucosal gastric calcinosis in a hypocalcaemic patient.
Dincay D., Atay K., Hatemi I., Kepil N., Keskin F. E., Apaydin T., et al.
Przeglad gastroenterologiczny
, cilt.12, sa.1, ss.70-71, 2017 (Scopus)
2017
201736. Evaluation of non-invasive diagnostic methods as indicators of fibrosis in patients with nonalcoholic fatty liver disease
Atay K., Canbakan B., Alan Ö., Koroglu E., Hatemi I., Kepil N., et al.
BIOMEDICAL RESEARCH-INDIA
, sa.2, ss.565-570, 2017 (SCI-Expanded)
2017
201737. Fatal gastrointestinal bleeding and perforated duodenal ulcer: a rare complication of deferasirox in a patient with liver cirrhosis
Atay K., Eskazan T., Salihoglu A., HATEMİ A. İ.
BIOMEDICAL RESEARCH-INDIA
, cilt.28, sa.12, ss.5620-5622, 2017 (SCI-Expanded, Scopus)
2017
201738. Gastric Ulcers Related to The Transarterial Radioembolization of Yittrium-90 in A Patient with Paraganglioma
Atay K., Akkoc F. N., Samanci C., Gulsen F., Kepil N., Hatemi I.
ACTA GASTRO-ENTEROLOGICA BELGICA
, cilt.80, sa.1, ss.85-86, 2017 (SCI-Expanded, Scopus)
2017
201739. Systemic vasculitis and the gut
Hatemi I., Hatemi G., Çelik A. B.
CURRENT OPINION IN RHEUMATOLOGY
, cilt.29, sa.1, ss.33-38, 2017 (SCI-Expanded, Scopus)
2017
201740. Prevalence of osteoporosis, osteopenia and vitamin d deficiency in cirrhotic patients.
Atay K., Hatemi I., Durcan E., Eskazan T., Bozcan S., SAHUTOGLU T., et al.
BIOMEDICAL RESEARCH-INDIA
, cilt.28, sa.6, ss.2631-2635, 2017 (SCI-Expanded, Scopus)
2017
201741. Serum autoantibody positivity and its impact on the treatment response of the genotype 1 chronic hepatitis C.
Erdal G. S., Hatemi I., Atay K., Canbakan B., Ozdemir S., Tuncer M., et al.
BIOMEDICAL RESEARCH-INDIA
, cilt.28, sa.2, ss.866-868, 2017 (SCI-Expanded, Scopus)
2017
201742. Systemic vasculitis and the gut
Hatemi A. İ., Hatemi G., Çelik A. F.
CURRENT OPINION IN RHEUMATOLOGY , cilt.29, sa.1, ss.33-38, 2017 (SCI-Expanded, Scopus)
2016
201643. Fecal Calprotectin Level Is Useful in Identifying Active Disease in Behcet's Syndrome Patients with Gastrointestinal Involvement: A Controlled Study
Esatoglu S. N., Hatemi I., Ozguler Y., Hatemi G., Uzun H., Celik A. F., et al.
ARTHRITIS & RHEUMATOLOGY
, cilt.68, 2016 (SCI-Expanded, Scopus)
2016
201644. Role of oxidative stress and insulin resistance in disease severity of non-alcoholic fatty liver disease
KÖROĞLU E., CANBAKAN B., ATAY K., HATEMI I., TUNCER M., Dobrucalı A. M., et al.
TURKISH JOURNAL OF GASTROENTEROLOGY
, cilt.27, sa.4, ss.361-366, 2016 (SCI-Expanded, Scopus, TRDizin)
2016
201645. Five-year results of oral antiviral therapy in HBeAg-negative chronic Hepatitis B
Atay K., Hatemi I., Canbakan B., Koroglu E., Durcan E., Yurttas B., et al.
TURKISH JOURNAL OF GASTROENTEROLOGY
, cilt.27, sa.3, ss.279-283, 2016 (SCI-Expanded, Scopus, TRDizin)
2016
201646. Demographic characteristics of chronic pancreatitis patients in the era of endosonography: Experience of a single tertiary referral center in Turkey
ŞİŞMAN G., Koroglu E., Erzin Y. Z., Hatemi I., Tuncer M., ŞENTÜRK H.
Turkish Journal of Gastroenterology
, cilt.27, sa.3, ss.284-289, 2016 (SCI-Expanded, Scopus, TRDizin)
2016
201647. Characteristics, Treatment, and Long-Term Outcome of Gastrointestinal Involvement in Behcet’s Syndrome
HATEMİ A. İ., ESATOĞLU S. N., HATEMİ G., ERZİN Y. Z., YAZICI H., ÇELİK A. F.
MEDICINE , cilt.95, 2016 (SCI-Expanded, Scopus)
2016
201648. Evolution of a long-term follow-up cohort of Crohn's disease with complex perianal fistula: from antibiotic to combined AZA and anti-TNF based treatment ending up clinical and radiological healing with or without stoma
Erzin Y., Ercaliskan K., Hatemi I., Atay K., Bozcan S., Demir N., et al.
JOURNAL OF CROHNS & COLITIS
, cilt.10, 2016 (SCI-Expanded, Scopus)
2016
201649. Clinical predictors of a frequently relapsing disease course under 5-ASA amongst ulcerative colitis patients initially responding to induction therapy with 5-ASA and/or steroids
Atay K., Erzin Y., Hatemi I., Eskazan T., Serin I., Bozcan S., et al.
JOURNAL OF CROHNS & COLITIS
, cilt.10, 2016 (SCI-Expanded, Scopus)
2016
201650. Comparison of the familial and sporadic cases of inflammatory bowel diseases in long-term follow-up regarding step-up treatment, clinical, and biochemical parameters
Bozcan S., Hatemi I., Erzin Y., Ayan G., Satman A., Gundogdu T., et al.
JOURNAL OF CROHNS & COLITIS
, cilt.10, 2016 (SCI-Expanded, Scopus)
2016
201651. Characteristics, treatment, and long-term outcome of gastrointestinal involvement in behcet's syndrome a strobe-compliant observational study from a dedicated multidisciplinary center
Hatemi I., Esatoglu S. N., Hatemi G., Erzin Y. Z., Yazici H., Celik A. F.
Medicine (United States)
, cilt.95, sa.16, 2016 (SCI-Expanded, Scopus)
2015
201552. Double pylorus in a patient with Behçet's syndrome.
Hatemi I., Hatemi G., Erzin Y. Z., Aykut E., Çelik A. B.
Clinical and experimental rheumatology
, cilt.33, sa.6 Suppl 94, 2015 (SCI-Expanded, Scopus)
2015
201553. A reappraisal of the association between Behcet's disease, myelodysplastic syndrome and the presence of trisomy 8: a systematic literature review
Esatoglu S. N., Hatemi G., Çelik A. F., Hatemi I., Soysal T., Çelik A. B.
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY
, cilt.33, sa.6, 2015 (SCI-Expanded, Scopus)
2015
201554. TNF-alpha antagonists and thalidomide for the management of gastrointestinal Behcet's syndrome refractory to the conventional treatment modalities: a case series and review of the literature
Hatemi I., Hatemi G., Pamuk O. N., Erzin Y., Çelik A. B.
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY
, cilt.33, sa.6, 2015 (SCI-Expanded, Scopus)
2015
201555. TNF-alpha antagonists and thalidomide for the management of gastrointestinal Behçet's syndrome refractory to the conventional treatment modalities: a case series and review of the literature
Hatemi A. İ., Hatemi G., Pamuk Ö. N., Erzin Y. Z., Çelik A. F.
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , cilt.94, sa.6, ss.129-137, 2015 (SCI-Expanded, Scopus)
2015
201556. What is our success on complex perianal fistulae healing under optimal medical treatment ending up with ileostomy?
Erzin Y., Ercaliskan A., Hatemi I., Baca B., Demir N., Bal K., et al.
JOURNAL OF CROHNS & COLITIS
, cilt.9, 2015 (SCI-Expanded, Scopus)
2015
201557. Double pylorus in a patient with Behçet's syndrome.
Hatemi A. İ., Hatemi G., Erzin Y. Z., Çelik A. F.
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , cilt.94, sa.6, ss.138-140, 2015 (SCI-Expanded, Scopus)
2015
201558. Hematologic Malignancies Among 1740 Inflammatory Bowel Disease Patients: Long term follow up Data from a Tertiary Center
Salihoglu A., Serin N., Esatoglu N., Yilmaz H., Sengul Y., Hatemi I., et al.
JOURNAL OF CROHNS & COLITIS
, cilt.9, 2015 (SCI-Expanded, Scopus)
2014
201459. Acute colitis presenting with hematochezia in a patient with chronic myeloid leukemia during dasatinib therapy
Eskazan A. E., Hatemi I., Aydin S. O., Ar M. C., Soysal T.
TURKISH JOURNAL OF GASTROENTEROLOGY
, cilt.25, ss.233, 2014 (SCI-Expanded, Scopus, TRDizin)
2014
201460. Routinely evaluated clinical assays and laboratory tests [real test] and fibrosis stages of chronic hepatitis B and C
Bugdaci M. S., KORKMAZ H., Demir A., BIYIK M., Temel T., GÖKTÜRK H. S., et al.
TURKISH JOURNAL OF GASTROENTEROLOGY
, cilt.25, sa.5, ss.539-545, 2014 (SCI-Expanded, Scopus, TRDizin)
2014
201461. Familial chylomicronemia syndrome related chronic pancreatitis: a single-center study
Sisman G., Erzin Y., Hatemi I., Caglar E., Boga S., Singh V., et al.
HEPATOBILIARY & PANCREATIC DISEASES INTERNATIONAL
, cilt.13, sa.2, ss.209-214, 2014 (SCI-Expanded, Scopus)
2014
201462. The clinical comparative demographic features between inpatient and outpatient of IBD
Sadri S., Hatemi I., Erzin Y., Baca B., Celik A. F.
JOURNAL OF CROHNS & COLITIS
, cilt.8, 2014 (SCI-Expanded, Scopus)
2014
201463. Demographic features and long-term follow up outcome comparisons between patients with solo inflammatory bowel disease vs. inflammatory bowel disease and concomitant ankylosing spondylitis
Erzin Y., Eyvazov H., Hatemi I., Hatemi G., Celik A. F.
JOURNAL OF CROHNS & COLITIS
, cilt.8, 2014 (SCI-Expanded, Scopus)
2014
201464. Comparative retrospective assessment of prospectively recorded endoscopic and histological findings between CD and GI-TB; the first Eastern European registry data
Erzin Y., Esatoglu S. N., Hatemi I., Demir N., Dogusoy G., Erdamar S., et al.
JOURNAL OF CROHNS & COLITIS
, cilt.8, 2014 (SCI-Expanded, Scopus)
2014
201465. What is the real value of acid fast staining, PCR, and culture of endoscopically obtained tissue samples in diagnosis of gastrointestinal tuberculosis in patients with ileocecal inflammation? Comparative data from an Eastern European registry
Erzin Y., Hatemi I., Kuskucu M. A., Aygun G., Midilli K., Esatoglu S. N., et al.
JOURNAL OF CROHNS & COLITIS
, cilt.8, 2014 (SCI-Expanded, Scopus)
2014
201466. What is our success on complex perianal fistula healing in the clinic? From antibiotic to combined anti-TNF based treatment, ending with or without ileostomy
Erzin Y., Ercaliskan A., Hatemi I., Eyice D., Baca B., Demir N., et al.
JOURNAL OF CROHNS & COLITIS
, cilt.8, 2014 (SCI-Expanded, Scopus)
2014
201467. Management of gastrointestinal Behcet's disease refractory to conventional treatment
Hatemi I., Hatemi G., Erzin Y., Celik A. F.
JOURNAL OF CROHNS & COLITIS
, cilt.8, 2014 (SCI-Expanded, Scopus)
2014
201468. Bone marrow transplantation for Behçet's disease: A case report and systematic review of the literature
Soysal T., Salihoglu A., Esatoglu S. N., Gulturk E., Eskazan A. E., Hatemi G., et al.
Rheumatology (United Kingdom)
, cilt.53, sa.6, ss.1136-1141, 2014 (SCI-Expanded, Scopus)
2013
201369. Concordance of Endoscopic Ultrasonography-Guided Fine Needle Aspiration Diagnosis with the Final Diagnosis in Subepithelial Lesions
Caglar E., HATEMİ A. İ., Atasoy D., Sisman G., ŞENTÜRK H.
CLINICAL ENDOSCOPY
, cilt.46, sa.4, ss.379-383, 2013 (ESCI, Scopus)
2013
201370. CHARACTERISTICS, TREATMENT AND OUTCOME OF GI INVOLVEMENT IN BEHCET SYNDROME: EXPERIENCE IN A DEDICATED CENTER
Hatemi I., Hatemi G., Erzin Y., Celik A. F., Yazici H.
ANNALS OF THE RHEUMATIC DISEASES
, cilt.71, ss.391, 2013 (SCI-Expanded, Scopus)
2013
201371. Massive Gastrointestinal Bleeding During the Course of Chronic Myelomonocytic Leukemia
SALIHOGLU A., HATEMI I., SENEL T. E., Aki H., FERHANOGLU B.
JOURNAL OF GASTROINTESTINAL AND LIVER DISEASES
, cilt.22, sa.1, ss.7, 2013 (SCI-Expanded, Scopus)
2012
201272. Endosonography-assisted transmural endoscopic drainage of pancreatic pseudocysts: A single center experience
Sisman G., Hatemi I., Erzin Y., Coskun M., Tuncer M., ŞENTÜRK H.
TURKISH JOURNAL OF GASTROENTEROLOGY
, cilt.23, sa.6, ss.741-746, 2012 (SCI-Expanded, Scopus, TRDizin)
2012
201273. NPRL2 gene expression in the progression of colon tumors
Yogurtcu B., Hatemi I., Aydın İ., Buyru N.
GENETICS AND MOLECULAR RESEARCH
, cilt.11, sa.4, ss.4810-4816, 2012 (SCI-Expanded, Scopus)
2011
201174. Collagenous Colitis: A Retrospective Survey of Patients with Chronic Diarrhea
Hatemi A. İ., Senates E., Dobrucali A., Goksel S.
HEPATO-GASTROENTEROLOGY
, cilt.58, sa.112, ss.1963-1967, 2011 (SCI-Expanded, Scopus)
2011
201175. A rare case of primary systemic amyloidosis presenting with hepatic failure
Gullu B. E., Hatemi I., Ozbay G., Tuzuner N., Sonsuz A.
TURKISH JOURNAL OF GASTROENTEROLOGY
, cilt.22, sa.1, ss.113-114, 2011 (SCI-Expanded, Scopus, TRDizin)
2010
201076. Adult Langerhans cell histiocytosis and sclerosing cholangitis: a case report and review of the literature
Hatemi I., Baysal B., Senturk H., Behzatoglu K., Bozkurt E. R., Ozbay G.
HEPATOLOGY INTERNATIONAL
, cilt.4, sa.3, ss.653-658, 2010 (SCI-Expanded, Scopus)
2010
201077. A COMPARATIVE STUDY OF CLINICAL, ENDOSCOPIC AND HISTOLOGIC FINDINGS IN PATIENTS WITH GASTROINTESTINAL BEHCET'S DISEASE AND CROHN'S DISEASE
Celik A. F., Hatemi I., Hatemi G., Satir E., Erzin Y., Sisman G., et al.
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY
, cilt.28, sa.4, 2010 (SCI-Expanded, Scopus)
2010
201078. Mesalazine induced drug fever
Hatemi I., Goksu A., Dobrucali A. M.
JOURNAL OF GASTROINTESTINAL AND LIVER DISEASES
, cilt.19, sa.2, ss.222, 2010 (SCI-Expanded, Scopus)
2010
201079. Validation of Biochemical Markers for the Prediction of Liver Fibrosis and Activity in Hemodialysis Patients With Chronic Hepatitis C
Senturk H., Canbakan M., Canbakan B., HATEMİ A. İ., Toptas T., Tabak Ö. F., et al.
GASTROENTEROLOGY
, cilt.138, sa.5, 2010 (SCI-Expanded, Scopus)
2010
201080. The Efficacy of Interferon Treatment in HBeAg Positive Chronic Hepatitis B is Very Low in an Area With Exclusively D Genotype
Senturk H., Baysal B., Ozaras R., Zerdali H., Tabak F., Mert A., et al.
GASTROENTEROLOGY
, cilt.138, sa.5, 2010 (SCI-Expanded, Scopus)
2010
201081. Anti-Saccharomyces cerevisiae (ASCA) antibody levels in a subgroup of patients with ulcerative colitis, Crohn's disease, GI Behcet, and GI tuberculosis: Correlations with disease duration, activity, and extension
Aslan M., Kocazeybek B., Celik A., Erzin Y., Hatemi I., Hatemi G., et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
, cilt.14, 2010 (SCI-Expanded, Scopus)
2010
201082. Clinical utility of perinuclear antineutrophil cytoplasmic antibodies and anti-Saccharomyces Cerevisiae antibodies for discriminating specific intestinal inflammations
Kocazeybek B., Aslan M., Erzin Y., Celik A., Hatemi I., Hatemi G., et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
, cilt.14, 2010 (SCI-Expanded, Scopus)
2008
200883. Frequency of pathergy phenomenon and other features of Behçet`s syndrome among patients with inflammatory bowel disease
Hatemi A. İ., Çelik A. F., Hatemi G., Melikoğlu M., Arzuhal N., Mat C., et al.
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , cilt.50, sa.4, ss.91-95, 2008 (SCI-Expanded, Scopus)
2008
200884. Frequency of pathergy phenomenon and other features of Behçet's syndrome among patients with inflammatory bowel disease
Hatemi I., Hatemi G., Çelik A. B., Melikoglu M., Arzuhal N., Mat C., et al.
Clinical and Experimental Rheumatology
, cilt.26, 2008 (SCI-Expanded, Scopus)
2008
200885. Serum gamma-glutamyltranspeptidase distinguishes non-alcoholic fatty liver disease at high risk
Tahan V., Canbakan B., Balci H., DANE F., Akin H., Can G., et al.
HEPATO-GASTROENTEROLOGY
, cilt.55, sa.85, ss.1433-1438, 2008 (SCI-Expanded, Scopus)
2008
200886. Leptin in nonalcoholic fatty liver disease.
Canbakan B., Tahan V., Balci H., Hatemi I., Erer B., Ozbay G., et al.
Annals of hepatology
, cilt.7, sa.3, ss.249-54, 2008 (Scopus)
2008
200887. Correlation of clinical and histopathologic features of celiac disease
Dogusoy G. B., Esen T., Cetin S. E., Goksel S., Cullu F., Kutlu T., et al.
VIRCHOWS ARCHIV
, cilt.452, 2008 (SCI-Expanded, Scopus)
2008
200888. Low dose thalidomide in immunosupressive unresponsive IBD; Effectiviness and side effects
Hatemi I., Hatemi G., Senates E., Baysal B., Erzin Y., Celik A. F.
GASTROENTEROLOGY
, cilt.134, sa.4, 2008 (SCI-Expanded, Scopus)
2008
200889. Menetrier's disease coexisting with ulcerative colitis and sclerosing cholangitis
Hatemi I., Çağlar E., Aksoy D., Goksel S., Dobrucali A. M.
DIGESTIVE AND LIVER DISEASE
, cilt.40, sa.1, ss.78-79, 2008 (SCI-Expanded, Scopus)
2007
200790. Clinicopathologic features of tuberculous colitis diagnosed in endoscopic biopsies
Dogusoy G. B., Celik A. F., Cigerciogullari E., Goksel S., Cetin S. E., Baysal B., et al.
VIRCHOWS ARCHIV
, cilt.451, sa.2, ss.225, 2007 (SCI-Expanded, Scopus)
2007
200791. Clinical, biochemical and histological correlations in a group of non-drinker subjects with non-alcoholic fatty liver disease
Canbakan B., Senturk H., TAHAN V., HATEMİ I., Balci H., Toptas T., et al.
ACTA GASTRO-ENTEROLOGICA BELGICA
, cilt.70, sa.3, ss.277-284, 2007 (SCI-Expanded, Scopus)
2006
200692. Comparison of virtual colonoscopy with conventional colonoscopy in detection of colorectal polyps.
Selcuk D., DEMIREL K., OZER H., BACA B., HATEMI I., Mihmanli I., et al.
The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology
, cilt.17, sa.4, ss.288-93, 2006 (Scopus, TRDizin)
2006
200693. Dense eosinophilic infiltration of the mucosa preceding ulcerative colitis and mimicking eosinophilic colitis: report of two cases.
Uzunismail H., Hatemi I., Doğusoy G., Akin O.
The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology
, cilt.17, sa.1, ss.53-7, 2006 (Scopus, TRDizin)
2005
200594. İnce bağırsak fizyolojisi ve motilite bozuklukları.
DOBRUCALI A. M., HATEMİ A. İ.
Türkiye Klinikleri Genel cerrahi.İnce bağırsak cerrahisi özel sayısı. 2005;1(8):3-12. , cilt.1, sa.8, ss.3-12, 2005 (Hakemli Dergi)
2004
200495. Massive haemorrhage induced by low molecular weight heparin in a patient with steroid refractory ulcerative colitis
Kaya S., Hatemi I., Hamzaoglu I., Uzunismail H.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY
, cilt.39, sa.6, ss.613, 2004 (SCI-Expanded, Scopus)
2003
200396. Screening for iron overload in the Turkish population
Barut G., Balci H., Bozdayi M., Hatemi I., Ozcelik D., Senturk H.
DIGESTIVE DISEASES
, cilt.21, sa.3, ss.279-285, 2003 (SCI-Expanded, Scopus)
1999
199997. Concomitant chronic lymphocytic leukemia and acute myeloid leukemia diagnosed by two color flow cytometric analysis
Yenerel M., HATEMİ A. İ., Keskin H.
HAEMATOLOGICA
, cilt.84, sa.8, ss.766-767, 1999 (SCI-Expanded, Scopus)
Hakemli Bilimsel Toplantılarda Yayımlanmış Bildiriler
2018
20181. The Evaluation of Cytogenetics Results Obtained from Behçet Disease with Gastrointestınal Involment
YILMAZ Ş., ESATOĞLU S. N., Kuru D., SALİHOĞLU A., ÇIRAKOĞLU A., HATEMİ G., et al.
13th National Congress of Medical Genetics with International Participation, Antalya, Türkiye, 7 - 11 Kasım 2018, ss.30, (Özet Bildiri)
2018
20182. IMMUNOGENICITY OF INFLIXIMAB AMONG PATIENTS WITH BEHCET'S SYNDROME: A CONTROLLED STUDY
Esatoglu S. N., Akkoc F. N., Ozguler Y., Ozbakir F., Nohut O. K., Cevirgen D., et al.
Congress of the European-League-Against-Rheumatism (EULAR), Amsterdam, Hollanda, 13 - 16 Haziran 2018, cilt.77, ss.767, (Özet Bildiri)
2017
20173. FECAL CALPROTECTIN LEVELS AS AN INDICATOR OF ACTIVE DISEASE IN BEHCET'S SYNDROME PATIENTS WITH GASTROINTESTINAL INVOLVEMENT: A CONTROLLED STUDY
Esatoglu S. N., Hatemi I., Ozguler Y., Hatemi G., Uzun H., Çelik A. B., et al.
Annual European Congress of Rheumatology, Madrid, İspanya, 14 - 17 Haziran 2017, cilt.76, ss.331, (Özet Bildiri)
2017
20174. FECAL CALPROTECTIN LEVEL LOOKS PROMISING IN IDENTIFYING ACTIVE DISEASE IN BEHCET'S SYNDROME PATIENTS WITH GASTROINTESTINAL INVOLVEMENT: A CONTROLLED AND PILOT STUDY
Esatoglu S. N., Hatemi I., Ozguler Y., Hatemi G., Uzun H., Celik A. F., et al.
18th International Vasculitis and ANCA Workshop, Tokyo, Japonya, 25 - 28 Mart 2017, cilt.56, ss.93, (Özet Bildiri)
2016
20165. Prevalence of Fecal Incontinence and Associated Risk Factors in Older Patients Outpatient Clinic
Yuruyen M., Demir N., Yavuzer H., Atay K., Demirdag F., Avci S., et al.
Annual Scientific Meeting of the American-Geriatrics-Society, California, Amerika Birleşik Devletleri, 19 - 21 Mayıs 2016, cilt.64, (Özet Bildiri)
2015
20156. LES pressure is not decreased in overweight patients with gastroesophageal reflux disease
Murt A., Hatemi I.
NeuroGASTRO Conference, İstanbul, Türkiye, 4 - 06 Haziran 2015, cilt.27, ss.87-88, (Özet Bildiri)
2015
20157. HEMATOLOGIC MALIGNANCIES, MOSTLY MYELODYSPLASTIC SYNDROMES AMONG 1740 INFLAMMATORY BOWEL DISEASE PATIENTS: LONG TERM FOLLOW-UP DATA FROM A TERTIARY CENTER
Salihoglu A., Serin N., Esatoglu N., Yilmaz H., Sengul Y., Hatemi I., et al.
20th Congress of European-Hematology-Association, Vienna, Avusturya, 11 - 14 Haziran 2015, cilt.100, ss.489, (Özet Bildiri)
2015
20158. Association Between Leptin Profile and Apoptosis in Patients With Metabolic Syndrome and Non-Alcoholic Fatty Liver Disease
Canbakan B., Senturk H., HATEMİ A. İ., Koroglu E., Tuncer M., Atay K., et al.
46th Annual Digestive Disease Week (DDW), Washington, Kiribati, 16 - 19 Mayıs 2015, cilt.148, (Özet Bildiri)
2015
20159. Osteoporosis in Chronic Liver Disease
Hatemi I., Durcan E., Atay K., Caliskan T., CANBAKAN B., Tuncer M.
46th Annual Digestive Disease Week (DDW), Washington, Kiribati, 16 - 19 Mayıs 2015, cilt.148, (Özet Bildiri)
2015
201510. DO LEPTIN PROFILE AND INSULIN RESISTANCE FAVOR OXIDATIVE STRESS AND DISEASE SEVERITY IN NON-ALCOHOLIC FATTY LIVER DISEASE?
Canbakan B., Senturk H., Hatemi I., Koroglu E., Tuncer M., Atay K., et al.
50th International Liver Congress of the European-Association-for-the-Study-of-the-Liver, Vienna, Avusturya, 22 - 26 Nisan 2015, cilt.62, (Özet Bildiri)
2014
201411. GASTROINTESTINAL INVOLVEMENT AMONG PATIENTS WITH SYSTEMIC VASCULITIS
Esatoglu N., Hatemi G., Hanel I., Hatemi I., Erzin Y., Pale A. S., et al.
15th Annual European Congress of Rheumatology (EULAR), Paris, Fransa, 11 - 14 Haziran 2014, cilt.73, ss.996, (Özet Bildiri)
2013
201312. Role of Oxidative Stress and Insulin Resistance in the Disease Severity of Non-Alcoholic Fatty Liver Disease
Canbakan B., Senturk H., Tuncer M., HATEMİ A. İ., Koroglu E., SONSUZ A., et al.
Digestive Disease Week / 28th Annual Residents and Fellows Research Conference of the Society-for-Surgery-of-the-Alimentary-Tract (SSAT), Florida, Amerika Birleşik Devletleri, 18 - 21 Mayıs 2013, cilt.144, (Özet Bildiri)
2012
201213. Characteristics, Treatment and Outcome of Gastrointestinal Involvement in Behcet's Syndrome: Experience in A Dedicated Center
Hatemi I., Hatemi G., Erzin Y., Celik A. F., Yazici H.
Annual Scientific Meeting of the American-College-of-Rheumatology (ACR) and Association-of-Rheumatology-Health-Professionals (ARHP), Washington, Kiribati, 9 - 14 Kasım 2012, cilt.64, (Özet Bildiri)
2012
201214. Insulin Resistance is Associated With Increased Apoptosis and Oxidative Stress in Non-Alcoholic Fatty Liver Disease
Canbakan B., Senturk H., Tuncer M., HATEMİ A. İ., Erzin Y., SONSUZ A., et al.
Digestive Disease Week (DDW), California, Amerika Birleşik Devletleri, 19 - 22 Mayıs 2012, cilt.142, (Özet Bildiri)
2011
201115. The Diagnostic Sensitivity and Specificity of the Endosonography(EUS) and EUS-Guided Fine Needle Aspiration Biopsy of Upper Gastrointestinal Subepithelial Lesions
Caglar E., Canbakan B., Senturk R., HATEMİ A. İ., Senturk H.
Conference on Digestive Disease Week 2011, Illinois, Amerika Birleşik Devletleri, 7 - 10 Mayıs 2011, cilt.140, (Özet Bildiri)
2011
201116. Hypertriglyceridemia Could Be an Etiological Factor in Chronic Pancreatitis
Sisman G., Senturk H., Hatemi A. İ., Senturk R., Ozdemir S.
Conference on Digestive Disease Week 2011, Illinois, Amerika Birleşik Devletleri, 7 - 10 Mayıs 2011, cilt.140, (Özet Bildiri)
2010
201017. IS ALANINE AMINOTRANSFERASE A SURROGATE MARKER OF SEVERE HEPATOCYTE APOPTOSIS IN PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE
Senturk H., Canbakan B., Canbakan M., Hatemi I., Toptas T., Tabak O., et al.
45th Annual Meeting of the European-Association-for-the-Study-of-the-Liver, Vienna, Avusturya, 14 - 18 Nisan 2010, cilt.52, (Özet Bildiri)
2008
200818. Interobserver reproducibility of histopathologic features in celiac disease and correlation with clinical findings
Esen T., Dogusoy G. B., Cetin S. E., Goksel S., Cullu F., Kutlu H., et al.
27th International Congress of the International-Academy-of-Pathology, Athens, Yunanistan, 12 - 17 Ekim 2008, cilt.53, ss.133-134, (Özet Bildiri)
2007
200719. Frequency of Behcet's syndrome among patients with inflammatory bowel disease
Hatemi G., Hatemi I., Celik A., Melikoglu M., Arzuhal N., Mat C., et al.
Annual European Congress of Rheumatology (EULAR 2007), Barcelona, İspanya, 13 - 16 Haziran 2007, cilt.66, ss.378, (Özet Bildiri)
2007
200720. Azathioprine toxicity in the treatment of inflammatory bowel disease: Outpatient clinic experience of seven years
HATEMİ A. İ., Baysal B., Senates E., Erzin Y., Celik A.
Digestive Disease Week Meeting/108th Annual Meeting of the American-Gastroenterological-Association, Washington, Kiribati, 19 - 24 Mayıs 2007, cilt.132, (Özet Bildiri)
2007
200721. Bone mineral density in corticosteroid naive Crohn's disease patients
Baysal B., HATEMİ A. İ., Senates E., Erzin Y., Celik A.
Digestive Disease Week Meeting/108th Annual Meeting of the American-Gastroenterological-Association, Washington, Kiribati, 19 - 24 Mayıs 2007, cilt.132, (Özet Bildiri)
2006
200622. Hepatocyte apoptosis in NAFLD patients with elevated versus normal GGT
Canbakan B., Senturk H., OLGAÇ N. V., Balci H., Guler S. D., Sut N., et al.
Digestive Disease Week Meeting/107th Annual Meeting of the American-Gastroenterlogical-Association, Los-Angeles, Şili, 20 - 25 Mayıs 2006, cilt.130, (Özet Bildiri)
2003
200323. Biochemical, radiological and histological correlates in patients with non-alcoholic fatty liver disease with or without ALT elevation
Canbakan B., Ozgulle S., Hatemi I., Ozbay G., Dirican A., Velet M., et al.
38th Annual Meeting of the European-Association-for-the-Study-of-the-Liver, İstanbul, Türkiye, 29 Mart - 01 Nisan 2003, cilt.38, ss.191-192, (Özet Bildiri)
2003
200324. A population survey for screening chronic liver diseases in 4261 individuals from Turkey
Hatemi I., Barut G., Balci H., Canbakan B., Yenice N., Senturk H.
38th Annual Meeting of the European-Association-for-the-Study-of-the-Liver, İstanbul, Türkiye, 29 Mart - 01 Nisan 2003, cilt.38, ss.216-217, (Özet Bildiri)
2003
200325. Biochemical, radiological, and histological correlates in patients with non-alcoholic fatty liver disease with elevated and normal liver enzymes
Canbakan B., Ozgulle S., HATEMİ A. İ., Velet M., Dirican A., SONSUZ A., et al.
Digestive Disease Week 2003 Meeting/104th Annual Meeting of the American-Gastroenterological-Association, ORLANDO, FLORIDA, 17 - 22 Mayıs 2003, cilt.124, (Özet Bildiri)
2002
200226. HFE mutation in Turkish population.
Barut G., Balci H., Bozdayi M., Hatemi I., Senturk H.
53rd Annual Meeting of the Association-for-the-Study-of-Liver-Diseases (AASLD), Massachusetts, Amerika Birleşik Devletleri, 1 - 05 Kasım 2002, cilt.36, (Özet Bildiri)
Desteklenen Projeler
2018 - 2023
2018 - 2023Behçet Hastalığında İntestinal Geçirgenlik ve Zonulin
Yükseköğretim Kurumları Destekli Proje , BAP Araştırma Projesi
HATEMİ G. (Yürütücü), ERDOĞAN M., ÖZBAKIR F., HATEMİ A. İ.
2021 - 2022
2021 - 2022
İmmunsupresif Tedavi Alan İnflamatuar Barsak Hastalıklarında Covid-19 Seroprevelansı ve Risk Faktörlerinin Belirlenmesi
Yükseköğretim Kurumları Destekli Proje , BAP Araştırma Projesi
ÇELİK A. F. (Yürütücü), ERZİN Y. Z., EŞKAZAN T., AYGÜN G., HATEMİ A. İ.
2014 - 2017
2014 - 2017Gastrointestinal tutulumlu Behçet hastalarındaki kromozom değişikliklerinin sitogenetik ve moleküler sitogenetik yöntemlerle değerlendirilmesi
Yükseköğretim Kurumları Destekli Proje , BAP Araştırma Projesi
SALİHOĞLU A. (Yürütücü), ESATOĞLU S. N., HATEMİ A. İ.
2014 - 2017
2014 - 2017Gastrointestinal Tutulumlu Behçet Hastalarındaki Kromozom Değişikliklerinin Sitogenetik ve Moleküler Sitogenetik Yöntemlerle Değerlendirilmesi
Yükseköğretim Kurumları Destekli Proje , BAP Araştırma Projesi
Kuru R. D., Esatoğlu S. N., Çırakoğlu A., Deviren A., Yılmaz Ş., Argüden Y., et al.
2016 - 2016
2016 - 2016Prevalence of Fecal Incontinence and Associated Risk Factors in Older Patients Outpatient Clinic
Yükseköğretim Kurumları Destekli Proje , BAP Diğer
YÜRÜYEN M. (Yürütücü), BEĞER T., DÖVENTAŞ A., ERDİNÇLER Ü. D., DOBRUCALI A. M., ATAY K., et al.
Bilimsel Dergilerdeki Faaliyetler
2023 - Devam Ediyor
2023 - Devam EdiyorCerrahpaşa Medical Journal
Baş Editör
Bilimsel Kuruluşlardaki Üyelikler / Görevler
2019 - Devam Ediyor
2019 - Devam EdiyorIBUS INTERNATIONAL BOWEL ULTRASOUND GROUP
Üye